COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS
The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of theadverse effects,such as steoporosis, weight gain and edema, due to the use ofPPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazoneder...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CALVANI, MENOTTI D'IDDIO, STEFANIA BENATTI, PAOLA |
| description | The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of theadverse effects,such as steoporosis, weight gain and edema, due to the use ofPPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazonederivative selected fromthe group consisting ofroglitazone, pioglitazone androsiglitazone.
La présente invention porte sur l'utilisation de la L-carnitine acétyle, ou d'un sel pharmaceutiquement acceptable de celle-ci, pour la prévention d'effets secondaires, tels que l'ostéoporose, le gain de poids et un oeème, dus à l'utilisation d'agonistes de PPAR-gamma choisis dans le groupe constitué par la spirolaxine ou un dérivé de glitazone choisi dans le groupe constitué par la roglitazone, la pioglitazone et la rosiglitazone. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2008141897A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2008141897A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2008141897A13</originalsourceid><addsrcrecordid>eNqNy70KwjAUhuEsDqLewwHnQqOC7RjSkzZgc0J-6iSlSJxEC_X-UYsX4PQN7_Mt2UVSa8nroMlA9KjiCRQ5CA2CddihmQspEFWHziOgUigDVBEh0Ow-ty-wVrisFm0rQNRktA9-zRa34T6lzW9XbKswyCZL47NP0zhc0yO9-jPt8rzgB16UR8H3_6k3oaEzWQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS</title><source>esp@cenet</source><creator>CALVANI, MENOTTI ; D'IDDIO, STEFANIA ; BENATTI, PAOLA</creator><creatorcontrib>CALVANI, MENOTTI ; D'IDDIO, STEFANIA ; BENATTI, PAOLA</creatorcontrib><description>The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of theadverse effects,such as steoporosis, weight gain and edema, due to the use ofPPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazonederivative selected fromthe group consisting ofroglitazone, pioglitazone androsiglitazone.
La présente invention porte sur l'utilisation de la L-carnitine acétyle, ou d'un sel pharmaceutiquement acceptable de celle-ci, pour la prévention d'effets secondaires, tels que l'ostéoporose, le gain de poids et un oeème, dus à l'utilisation d'agonistes de PPAR-gamma choisis dans le groupe constitué par la spirolaxine ou un dérivé de glitazone choisi dans le groupe constitué par la roglitazone, la pioglitazone et la rosiglitazone.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20081127&DB=EPODOC&CC=WO&NR=2008141897A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20081127&DB=EPODOC&CC=WO&NR=2008141897A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CALVANI, MENOTTI</creatorcontrib><creatorcontrib>D'IDDIO, STEFANIA</creatorcontrib><creatorcontrib>BENATTI, PAOLA</creatorcontrib><title>COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS</title><description>The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of theadverse effects,such as steoporosis, weight gain and edema, due to the use ofPPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazonederivative selected fromthe group consisting ofroglitazone, pioglitazone androsiglitazone.
La présente invention porte sur l'utilisation de la L-carnitine acétyle, ou d'un sel pharmaceutiquement acceptable de celle-ci, pour la prévention d'effets secondaires, tels que l'ostéoporose, le gain de poids et un oeème, dus à l'utilisation d'agonistes de PPAR-gamma choisis dans le groupe constitué par la spirolaxine ou un dérivé de glitazone choisi dans le groupe constitué par la roglitazone, la pioglitazone et la rosiglitazone.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy70KwjAUhuEsDqLewwHnQqOC7RjSkzZgc0J-6iSlSJxEC_X-UYsX4PQN7_Mt2UVSa8nroMlA9KjiCRQ5CA2CddihmQspEFWHziOgUigDVBEh0Ow-ty-wVrisFm0rQNRktA9-zRa34T6lzW9XbKswyCZL47NP0zhc0yO9-jPt8rzgB16UR8H3_6k3oaEzWQ</recordid><startdate>20081127</startdate><enddate>20081127</enddate><creator>CALVANI, MENOTTI</creator><creator>D'IDDIO, STEFANIA</creator><creator>BENATTI, PAOLA</creator><scope>EVB</scope></search><sort><creationdate>20081127</creationdate><title>COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS</title><author>CALVANI, MENOTTI ; D'IDDIO, STEFANIA ; BENATTI, PAOLA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2008141897A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2008</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CALVANI, MENOTTI</creatorcontrib><creatorcontrib>D'IDDIO, STEFANIA</creatorcontrib><creatorcontrib>BENATTI, PAOLA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CALVANI, MENOTTI</au><au>D'IDDIO, STEFANIA</au><au>BENATTI, PAOLA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS</title><date>2008-11-27</date><risdate>2008</risdate><abstract>The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of theadverse effects,such as steoporosis, weight gain and edema, due to the use ofPPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazonederivative selected fromthe group consisting ofroglitazone, pioglitazone androsiglitazone.
La présente invention porte sur l'utilisation de la L-carnitine acétyle, ou d'un sel pharmaceutiquement acceptable de celle-ci, pour la prévention d'effets secondaires, tels que l'ostéoporose, le gain de poids et un oeème, dus à l'utilisation d'agonistes de PPAR-gamma choisis dans le groupe constitué par la spirolaxine ou un dérivé de glitazone choisi dans le groupe constitué par la roglitazone, la pioglitazone et la rosiglitazone.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2008141897A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A55%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CALVANI,%20MENOTTI&rft.date=2008-11-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2008141897A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |